Drug Profile
Changrolin
Alternative Names: PyrozolineLatest Information Update: 02 Sep 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source; Shanghai Second Medical University
- Developer Shanghai Second Medical University
- Class Antiarrhythmics
- Mechanism of Action Calcium channel antagonists; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Arrhythmias in Japan (IV)
- 23 Jun 1995 No-Development-Reported for Arrhythmias in China (IV)
- 23 Jun 1995 Preclinical development for Arrhythmias in Japan (IV)